Cargando…
Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Despite recent advances in the development of targeted therapies, patients with advanced disease remain incurable, mostly because metastatic non-small cell lung carcinomas (NSCLC) eventually become resistant...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263601/ https://www.ncbi.nlm.nih.gov/pubmed/25501935 http://dx.doi.org/10.1371/journal.pone.0114131 |